Levetiracetam Maintenance Dosing for a 12-Year-Old, 75kg Patient
For a 12-year-old weighing 75kg, the appropriate maintenance dose of Focale (levetiracetam) is 1500 mg twice daily (3000 mg/day total), which can be administered as three 500mg tablets twice daily.
Weight-Based Dosing Algorithm
Since this patient weighs >40 kg, they fall into the adult dosing category per FDA guidelines 1:
- Initial dose: 500 mg twice daily (1000 mg/day total) 1
- Titration: Increase by 1000 mg/day every 2 weeks 1
- Target maintenance dose: 1500 mg twice daily (3000 mg/day total) 1
The FDA label specifically states that for pediatric patients >40 kg, the recommended daily dose is 3000 mg/day (administered as 2 × 750 mg tablets BID, or equivalently 3 × 500 mg tablets BID) 1.
Clinical Context for Seizure Type
For Partial Onset Seizures
- Patients >40 kg should receive 3000 mg/day divided twice daily as the target maintenance dose 1
- This represents 40 mg/kg/day for this 75kg patient, which is within the recommended range 1
For Primary Generalized Tonic-Clonic Seizures
- The same dosing applies: 3000 mg/day (1500 mg BID) for patients >40 kg 1
- Doses lower than 3000 mg/day have not been adequately studied for efficacy 1
For Myoclonic Seizures (if applicable at age 12+)
- Target dose remains 3000 mg/day (1500 mg BID) 1
- Effectiveness of lower doses has not been established 1
Practical Administration
Using 500mg tablets (Focale 500mg):
- Morning dose: 3 tablets (1500 mg)
- Evening dose: 3 tablets (1500 mg)
- Can be taken with or without food 1
Important Caveats
Renal Function Considerations
- Critical: Levetiracetam is primarily renally cleared, and dose adjustments are necessary in renal dysfunction 2, 3
- If this patient has any renal impairment, doses must be reduced based on creatinine clearance 1
- In patients with CrCl 10-30 mL/min, maintenance dosing should be reduced to 500-1000 mg every 12 hours 1
Titration Timeline
- Do not start at the full 3000 mg/day dose 1
- Begin with 1000 mg/day (500 mg BID) and increase by 1000 mg/day increments every 2 weeks 1
- This gradual titration minimizes CNS-related adverse effects (somnolence, asthenia, dizziness) that occur predominantly in the first 4 weeks 4
Maximum Dosing
- While 3000 mg/day is the recommended dose, doses up to 4500 mg have been used in open-label studies 1
- However, there is no evidence that doses >3000 mg/day confer additional benefit 1
- Recent evidence suggests that for status epilepticus, loading doses of 40 mg/kg (3000 mg for this patient) provide adequate therapeutic levels 5
Common Pitfalls to Avoid
- Underdosing: The American Academy of Neurology warns against using prophylactic doses when therapeutic doses are needed 2
- Inadequate measuring: Only whole tablets should be administered; do not split tablets 1
- Premature discontinuation: Most adverse effects are mild-to-moderate and occur in the first 4 weeks of treatment 4